Semax Research Guide: ACTH Analog, BDNF Upregulation, and Cognitive Biology

Semax 10mg research peptide vial
A research-focused guide to Semax, a synthetic ACTH(4-7) heptapeptide analog studied for BDNF upregulation, neuroprotection, cognitive biology, and stroke recovery models.

Explore our full guide to nootropic peptides for cognitive research to see how this compares.

Semax is a synthetic peptide, seven amino acids long (Met-Glu-His-Phe-Pro-Gly-Pro), that researchers study for memory, focus, and brain protection. It’s built from a small piece of the natural hormone ACTH. In lab studies it lifts BDNF, one of the brain’s key growth signals.[2]

This article is for research and educational use only. Semax is a research compound, not a medicine, and isn’t for human use.

It came out of the Institute of Molecular Genetics in Moscow. The design takes the ACTH 4-7 core and bolts on a Pro-Gly-Pro tail so the body breaks it down more slowly. That tail is the whole trick. Plain ACTH 4-7 falls apart within minutes, but the modified peptide hangs around long enough to reach the brain through a nasal spray. Russia approved it for stroke recovery back in the 1990s. This guide covers the mechanism of action, what the research shows on BDNF, thinking, stroke recovery, and ADHD, how it stacks up against Selank, and what to know about dosing and sourcing.

What is Semax and how does it work?

It works by raising brain growth signals and tuning several brain chemicals at the same time. Dolotov and colleagues, in the Journal of Neurochemistry, showed the peptide is a copy of that small ACTH fragment carrying the Pro-Gly-Pro tail that helps it resist breakdown.[1] Here’s the useful part. Unlike the full ACTH hormone, it doesn’t trigger cortisol, the stress hormone, so it sidesteps the whole stress-axis response.

There’s no single receptor doing the work. It seems to act through melanocortin-related pathways while nudging several neurotransmitter systems directly. Those threads pull together into three headline effects: more BDNF, a stronger dopamine system, and a calmer immune response inside the brain. That neuroprotective, multi-target profile is what makes it interesting as a research tool.

Semax and BDNF signaling

Its best-known move is raising BDNF, the protein that helps brain cells grow and wire together. Dmitrieva and colleagues, in Cellular and Molecular Neurobiology, found it lifted the activity of the BDNF gene and its TrkA and TrkC receptors in the rat brain.[2] That double hit matters. Raising the growth signal and its receptors together makes for a longer-lasting effect, the kind that feeds brain plasticity, switches on protective genes, and underpins the learning and memory benefits the peptide is known for.

BDNF is the master dial for plasticity in the adult brain. When it runs low, you see it shadowing memory decline, depression, and slow recovery after stroke. Pushing it back up is the leading explanation for the peptide’s cognitive and stroke-recovery effects.

Does Semax increase dopamine levels?

It does. Eremin and colleagues, in Neurochemical Research, showed it boosted dopamine release in the striatum and revved up the activity of dopamine neurons in the substantia nigra.[3] That’s a big reason it gets studied as a research nootropic for focus and attention, and it speaks to its nootropic properties more broadly.

The reach goes further. A 2006 Brain Research paper from the same Moscow group showed it also tunes BDNF and TrkB in the hippocampus and touches serotonin, acetylcholine, and other systems.[4] Working across many systems at once is exactly what gives it such a broad set of cognitive effects.

Is Semax good for ADHD or improving focus?

It’s studied for ADHD precisely because of that dopamine effect. Russian clinical research lists ADHD as one approved use, with reports of better attention, sharper focus, and less impulsivity in children and adults. The logic holds up: most ADHD drugs work through dopamine, and this peptide offers a route that doesn’t block monoamine reuptake the way stimulants do.

The effect is smaller than methylphenidate or amphetamine. The side effects are gentler too. For researchers, that combination makes it handy for teasing dopamine-driven changes apart from the rest of the cognitive picture.

Can Semax help with brain fog?

It’s studied for the cluster people call “brain fog,” even though that isn’t a real diagnosis. The label covers slow thinking, trouble concentrating, and mental fatigue, which overlap with what the peptide has been tested against. Russian research uses it for “asthenic” syndromes, meaning mental and physical exhaustion, and reports modest cognitive gains over 2-to-4-week windows. The proposed drivers are familiar by now: more BDNF, steadier dopamine support, and a calmer brain immune response that may take the edge off inflammation-driven fog.

Semax in stroke recovery research

Stroke recovery is its most clinically tested use. Russia approves it for ischemic stroke and mini-strokes, the transient ischemic attacks, given inside the early recovery window. The protection is thought to come from three places at once: BDNF-driven cell survival, dopamine support for motor and thinking recovery, and a quieter immune response that limits second-wave damage. Medvedeva and colleagues, in BMC Genomics, found the immune response was the single process most strongly shifted in stroke-injured brain tissue, which hints that a good chunk of the benefit runs through less brain inflammation rather than direct action on neurons alone.[5]

Semax vs Selank: nootropic peptide comparison

One line sums it up: Semax is for focus, Selank is for calm. Both are Russian-made and built the same way, a Pro-Gly-Pro tail added to a natural peptide fragment, but they pull in different directions. Semax comes from ACTH and mainly raises BDNF and dopamine while calming the brain’s immune response, which lands as energizing and focus-boosting. Selank comes from tuftsin and mostly supports GABA to ease anxiety, so it reads as calming with a little cognitive lift on the side. Researchers often run them together, using Semax for daytime focus and Selank to manage stress.

Routes of administration and dosage

The main Russian form is a nasal spray, either a 0.1 percent or 1 percent solution. That nose-to-brain path is clever: it lets the peptide reach the brain without fully crossing the blood-brain barrier, which trips up most peptides. Research protocols also use injection under the skin or into muscle. Russian-approved doses tend to run 200 to 500 micrograms per dose, two to three times a day by spray. Research doses can go higher, depending on the question being asked about Semax administration.

Safety and side effects of Semax

After three decades of Russian use, the reported side effects are minimal. The common ones are mild nasal irritation from the spray, the occasional brief headache, and trouble sleeping if it’s dosed too late in the day. No liver, heart, or whole-body problems have surfaced. Inside approved dose ranges, it’s regarded as safe.

Legal status and where to find Semax

It’s approved in Russia and a few nearby countries as a finished medicine. It hasn’t been cleared by Health Canada or the FDA. Research-grade material can be sold to Canadian and US labs for laboratory research only, and it isn’t on the World Anti-Doping Agency banned list.

Reviv Peptides supplies research-grade Semax with a third-party COA and HPLC purity confirmation. View the Semax product page.

Semax sells legally in Canada as a research chemical rather than an approved medicine, and our guide to the Canadian legal framework for buying peptides walks through what that status means.

Sourcing considerations for researchers

Semax research lives or dies on clean readouts, whether that is BDNF gene activity, dopamine release, or behavioral scores, so a mislabeled or impure batch can hand you effects that are not Semax at all. It is an ACTH(4-10) analog, and a stray related fragment or a wrong sequence could stir up off-target melanocortin or stress-axis activity and muddy the very cognitive endpoints you are measuring. So pin down the identity first. Ask for mass spectrometry matching the seven-amino-acid peptide’s expected weight near 813 Da, HPLC purity of 98 percent or higher with the chromatogram trace attached, and an outside lab’s certificate for that exact batch rather than the maker’s in-house QC. For cell-culture or in-vivo work, add endotoxin and sterility testing.

Semax questions

What are the effects and benefits of Semax?

More BDNF and its receptors, a stronger dopamine system, a calmer brain immune response, brain protection after stroke, and modest gains in attention and focus. Russian approval covers ischemic stroke, mini-strokes, optic nerve damage, and fatigue syndromes.

Is Semax effective for ADHD or improving focus and attention?

Russian research lists ADHD as a use, with reports of modest gains in attention and focus that fit its dopamine effect. The effect is smaller than stimulant drugs but with gentler side effects.

Does Semax influence dopamine levels or other neurotransmitters?

Yes. It raises dopamine release in the striatum and also adjusts serotonin, acetylcholine, glutamate, and GABA. Touching many systems is the basis for its wide cognitive effects.

Can Semax help with brain fog and cognitive enhancement?

In Russian research it improves the thinking symptoms grouped under “asthenic” syndromes, meaning mental fatigue and slow processing. The proposed mechanism is more BDNF and a calmer brain immune response that may ease inflammation-driven fog.

What is Semax and how does it work?

It’s a synthetic seven-amino-acid peptide copied from the ACTH 4-7 fragment with a Pro-Gly-Pro tail for stability. It works by raising BDNF, boosting dopamine, calming the brain immune response, and rebalancing other brain chemicals.

Key data point: across replicated rodent studies, Semax raised BDNF gene activity and its TrkA and TrkC receptors in the hippocampus and cortex, an effect larger than its short time in the body would predict.[2]

Summary

Semax is one of the most clinically tested nootropic peptides in the scientific literature, with three decades of Russian use spanning stroke recovery, fatigue syndromes, ADHD, and optic nerve damage. The mechanism comes down to more BDNF, more dopamine, and a calmer brain immune response. It’s given most often by nasal spray, with injection reserved for research. The safety record is good, the effects modest but steady. It isn’t approved in Canada or the United States and sells as a research chemical for laboratory research only. For anyone studying brain growth signals, dopamine, or peptide angles on ADHD, it’s one of the best-characterized tool peptides on the shelf.

Sources: [1] Semax binds and raises BDNF in rat basal forebrain (ACTH 4-10 analog), PubMed. [2] Semax activates neurotrophin and receptor genes after ischemia, PubMed. [3] Semax activates dopaminergic and serotoninergic systems, PubMed. [4] Semax regulates BDNF and TrkB in the hippocampus, PubMed. [5] Semax affects immune and vascular genes in brain ischemia, PubMed.

Share the Post:

Related Posts

Join Our Newsletter